THERAVANCE INC

Historical 13F Holders

CUSIP
88338TAB0
All holders as of
Q2 2025
Type
Debt
Class
NOTE 2.125% 1/1
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 2 1.00 $1.00
2025 Q1 2 1.00 $1.00
2024 Q4 2 1.00 $1.00
2024 Q3 2 1.00 $1.00
2024 Q2 2 1.00 $1.00
2024 Q1 2 1.00 $1.00
2023 Q4 2 1.00 $1.00
2023 Q3 2 1.00 $1.00
2023 Q2 2 1.00 $1.00
2023 Q1 2 1.00 $1.00
2022 Q4 21 96.3 M $96.2 M
2022 Q3 20 94.5 M $93.2 M
2022 Q2 21 102 M $101 M
2022 Q1 19 80.9 M $102 M
2021 Q4 25 222 M $260 M
2021 Q3 36 229 M $256 M
2021 Q2 31 220 M $237 M
2021 Q1 31 228 M $253 M
2020 Q4 32 238 M $239 M
2020 Q3 33 231 M $223 M
2020 Q2 32 234 M $249 M
2020 Q1 34 236 M $226 M
2019 Q4 30 229 M $231 M
2019 Q3 26 226 M $221 M
2019 Q2 25 231 M $254 M
2019 Q1 25 239 M $244 M
2018 Q4 32 249 M $277 M
2018 Q3 33 216 M $232 M
2018 Q2 35 214 M $231 M
2018 Q1 36 200 M $266 M
2017 Q4 35 184 M $248 M
2017 Q3 29 203 M $239 M
2017 Q2 34 241 M $220 M
2017 Q1 29 238 M $226 M
2016 Q4 22 228 M $194 M
2016 Q3 21 232 M $197 M
2016 Q2 18 224 M $188 M
2016 Q1 20 243 M $192 M
2015 Q4 22 318 M $241 M
2015 Q3 24 275 M $183 M
2015 Q2 25 244 M $231 M
2015 Q1 23 250 M $215 M
2014 Q4 23 255 M $199 M
2014 Q3 22 253 M $284 M
2014 Q2 24 281 M $469 M
2014 Q1 26 281 M $363 M